Fig. 2From: A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trialTreatment exposure and response duration of the enrolled patients. CR complete response, PD progressive disease, PR partial response, SD stable disease, VGPR very good partial responseBack to article page